According to GRiD research
"Unlocking the immense potential that neurodivergent minds bring to the table"
Following 25% equity stake in the start-up
Online ‘matching’ platform launched to assign treatment
Amid amalgamation with Aspira
To discuss challenges around the Consumer Duty implementation